MiR-25 has also been shown to promote proliferation in triple-negative breast cancer cells by repression of the BTG anti-proliferation factor 2 [68] whereas miR-106b has been shown to induce proliferation by targeting RB proteins in various cancers [69, 70]. This evidence concerns the gene RB1 and triple-negative breast carcinoma.